

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.21017420 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 5.89123757 |
| 3 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.64924374 |
| 4 | vocalization behavior (GO:0071625) | 5.62265213 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.47503800 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.37601349 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.27517226 |
| 8 | glutamate secretion (GO:0014047) | 5.25971540 |
| 9 | locomotory exploration behavior (GO:0035641) | 5.15954682 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.14646643 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.13140515 |
| 12 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.83309789 |
| 13 | neuronal action potential propagation (GO:0019227) | 4.80309670 |
| 14 | protein localization to synapse (GO:0035418) | 4.72196062 |
| 15 | central nervous system myelination (GO:0022010) | 4.66513931 |
| 16 | axon ensheathment in central nervous system (GO:0032291) | 4.66513931 |
| 17 | neuron cell-cell adhesion (GO:0007158) | 4.40415584 |
| 18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.37795597 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.34723125 |
| 20 | neuron-neuron synaptic transmission (GO:0007270) | 4.27476100 |
| 21 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.23010524 |
| 22 | L-amino acid import (GO:0043092) | 4.21748876 |
| 23 | neurotransmitter secretion (GO:0007269) | 4.17934561 |
| 24 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.15925190 |
| 25 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.10456752 |
| 26 | synaptic transmission, glutamatergic (GO:0035249) | 4.08532275 |
| 27 | positive regulation of neurotransmitter secretion (GO:0001956) | 4.01507040 |
| 28 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.98484233 |
| 29 | sodium ion export (GO:0071436) | 3.97946434 |
| 30 | exploration behavior (GO:0035640) | 3.96686145 |
| 31 | regulation of synapse structural plasticity (GO:0051823) | 3.90146306 |
| 32 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.88805098 |
| 33 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.87288166 |
| 34 | glutamate receptor signaling pathway (GO:0007215) | 3.86307152 |
| 35 | cerebellar granule cell differentiation (GO:0021707) | 3.84370967 |
| 36 | positive regulation of neurotransmitter transport (GO:0051590) | 3.81010530 |
| 37 | response to histamine (GO:0034776) | 3.77688603 |
| 38 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.77105240 |
| 39 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.76953253 |
| 40 | proline transport (GO:0015824) | 3.74706606 |
| 41 | long-term synaptic potentiation (GO:0060291) | 3.70994153 |
| 42 | regulation of postsynaptic membrane potential (GO:0060078) | 3.69603379 |
| 43 | positive regulation of membrane potential (GO:0045838) | 3.65415153 |
| 44 | positive regulation of synapse maturation (GO:0090129) | 3.61157130 |
| 45 | regulation of glutamate secretion (GO:0014048) | 3.54863351 |
| 46 | * regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.51342860 |
| 47 | layer formation in cerebral cortex (GO:0021819) | 3.51014923 |
| 48 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.51000051 |
| 49 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.48054109 |
| 50 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.46802761 |
| 51 | regulation of neurotransmitter secretion (GO:0046928) | 3.46437837 |
| 52 | regulation of synaptic plasticity (GO:0048167) | 3.46258816 |
| 53 | long-term memory (GO:0007616) | 3.45058531 |
| 54 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.42781612 |
| 55 | postsynaptic membrane organization (GO:0001941) | 3.40736176 |
| 56 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.39993625 |
| 57 | negative regulation of amino acid transport (GO:0051956) | 3.39099707 |
| 58 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.38575796 |
| 59 | gamma-aminobutyric acid transport (GO:0015812) | 3.35707902 |
| 60 | potassium ion import (GO:0010107) | 3.35563870 |
| 61 | presynaptic membrane assembly (GO:0097105) | 3.34403864 |
| 62 | amino acid import (GO:0043090) | 3.32926774 |
| 63 | neuromuscular synaptic transmission (GO:0007274) | 3.30651434 |
| 64 | transferrin transport (GO:0033572) | 3.29995540 |
| 65 | * negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.27680117 |
| 66 | activation of protein kinase A activity (GO:0034199) | 3.26828239 |
| 67 | positive regulation of dendritic spine development (GO:0060999) | 3.24564211 |
| 68 | neurotransmitter transport (GO:0006836) | 3.22771141 |
| 69 | neurotransmitter uptake (GO:0001504) | 3.21659838 |
| 70 | startle response (GO:0001964) | 3.21146707 |
| 71 | synaptic vesicle endocytosis (GO:0048488) | 3.20473805 |
| 72 | * behavioral response to cocaine (GO:0048148) | 3.18280342 |
| 73 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.17945798 |
| 74 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.17945798 |
| 75 | potassium ion homeostasis (GO:0055075) | 3.17336331 |
| 76 | neuromuscular process controlling posture (GO:0050884) | 3.16435929 |
| 77 | regulation of neurotransmitter transport (GO:0051588) | 3.14881999 |
| 78 | positive regulation of synaptic transmission (GO:0050806) | 3.12991596 |
| 79 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.11777423 |
| 80 | positive regulation of fibroblast migration (GO:0010763) | 3.11557712 |
| 81 | regulation of vesicle fusion (GO:0031338) | 3.11267183 |
| 82 | membrane depolarization (GO:0051899) | 3.09921969 |
| 83 | presynaptic membrane organization (GO:0097090) | 3.09789565 |
| 84 | regulation of neurotransmitter levels (GO:0001505) | 3.08547882 |
| 85 | regulation of dendritic spine development (GO:0060998) | 3.08529290 |
| 86 | mechanosensory behavior (GO:0007638) | 3.07954147 |
| 87 | ferric iron transport (GO:0015682) | 3.05268076 |
| 88 | trivalent inorganic cation transport (GO:0072512) | 3.05268076 |
| 89 | detection of calcium ion (GO:0005513) | 3.04991874 |
| 90 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.04925135 |
| 91 | primary amino compound metabolic process (GO:1901160) | 3.03617684 |
| 92 | neuronal ion channel clustering (GO:0045161) | 3.02839716 |
| 93 | negative regulation of appetite (GO:0032099) | 3.01671080 |
| 94 | negative regulation of response to food (GO:0032096) | 3.01671080 |
| 95 | neuron recognition (GO:0008038) | 3.00675459 |
| 96 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.00598244 |
| 97 | vesicle docking involved in exocytosis (GO:0006904) | 2.98735348 |
| 98 | cellular potassium ion transport (GO:0071804) | 2.96475022 |
| 99 | potassium ion transmembrane transport (GO:0071805) | 2.96475022 |
| 100 | dendritic spine morphogenesis (GO:0060997) | 2.96173294 |
| 101 | acidic amino acid transport (GO:0015800) | 2.94941937 |
| 102 | regulation of protein kinase A signaling (GO:0010738) | 2.93263978 |
| 103 | behavioral fear response (GO:0001662) | 2.93142236 |
| 104 | behavioral defense response (GO:0002209) | 2.93142236 |
| 105 | synaptic transmission, dopaminergic (GO:0001963) | 2.92611375 |
| 106 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.92375872 |
| 107 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.91898578 |
| 108 | negative regulation of dendrite development (GO:2000171) | 2.90473592 |
| 109 | response to gravity (GO:0009629) | 2.90245996 |
| 110 | regulation of sensory perception of pain (GO:0051930) | 2.89925327 |
| 111 | regulation of sensory perception (GO:0051931) | 2.89925327 |
| 112 | synaptic vesicle transport (GO:0048489) | 2.89114238 |
| 113 | establishment of synaptic vesicle localization (GO:0097480) | 2.89114238 |
| 114 | neuromuscular process controlling balance (GO:0050885) | 2.88878258 |
| 115 | response to auditory stimulus (GO:0010996) | 2.88368980 |
| 116 | membrane hyperpolarization (GO:0060081) | 2.88268082 |
| 117 | auditory behavior (GO:0031223) | 2.87852566 |
| 118 | cochlea development (GO:0090102) | 2.87473161 |
| 119 | learning (GO:0007612) | 2.87297224 |
| 120 | cellular potassium ion homeostasis (GO:0030007) | 2.85678624 |
| 121 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.85521816 |
| 122 | cellular sodium ion homeostasis (GO:0006883) | 2.85447098 |
| 123 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.84605512 |
| 124 | * synaptic transmission (GO:0007268) | 2.84518317 |
| 125 | membrane depolarization during action potential (GO:0086010) | 2.82591840 |
| 126 | * regulation of synaptic transmission (GO:0050804) | 2.81045365 |
| 127 | phagosome maturation (GO:0090382) | 2.81033512 |
| 128 | transmission of nerve impulse (GO:0019226) | 2.80147965 |
| 129 | long term synaptic depression (GO:0060292) | 2.78010188 |
| 130 | cellular response to ammonium ion (GO:0071242) | 2.75465469 |
| 131 | prepulse inhibition (GO:0060134) | 2.73944356 |
| 132 | * memory (GO:0007613) | 2.73514018 |
| 133 | serotonin metabolic process (GO:0042428) | 2.73338940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.71231211 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.29805868 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.26881512 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.18462921 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.13609324 |
| 6 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.79694804 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.65791080 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.65791080 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.61419531 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.59990684 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.56193183 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.55750938 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.53032040 |
| 14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.51614995 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.43990868 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.43325954 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.36607680 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.34095860 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.28606666 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.21000411 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.19776338 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.08887895 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.07284632 |
| 24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.03185430 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.96729351 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.93007125 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.92640821 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.89466931 |
| 29 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.85586902 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.76219040 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.76042416 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.75543026 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.74290638 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.69988068 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.69178223 |
| 36 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.69083702 |
| 37 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.65393045 |
| 38 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.54431207 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.52588535 |
| 40 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.50281993 |
| 41 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49277380 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49101579 |
| 43 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.48771230 |
| 44 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.43386429 |
| 45 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.42335721 |
| 46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.41725410 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40311138 |
| 48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37008182 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36961103 |
| 50 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.36470710 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.36400385 |
| 52 | TP53_16413492_ChIP-PET_HCT116_Human | 1.35849525 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34775687 |
| 54 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34287914 |
| 55 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34227083 |
| 56 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.32255980 |
| 57 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.28361642 |
| 58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.28265501 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.28265501 |
| 60 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24885931 |
| 61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24174835 |
| 62 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.22216308 |
| 63 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22216308 |
| 64 | JUN_21703547_ChIP-Seq_K562_Human | 1.21224072 |
| 65 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20777433 |
| 66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20424319 |
| 67 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20345187 |
| 68 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19734374 |
| 69 | FUS_26573619_Chip-Seq_HEK293_Human | 1.19493886 |
| 70 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19402771 |
| 71 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.18830994 |
| 72 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.18366764 |
| 73 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17368497 |
| 74 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17155826 |
| 75 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16850751 |
| 76 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.16364025 |
| 77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14198648 |
| 78 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13844098 |
| 79 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13341218 |
| 80 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12989004 |
| 81 | AR_19668381_ChIP-Seq_PC3_Human | 1.11997318 |
| 82 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.08627350 |
| 83 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08560868 |
| 84 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07381285 |
| 85 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.06974881 |
| 86 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06899074 |
| 87 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05944321 |
| 88 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05491395 |
| 89 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.05356270 |
| 90 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04663628 |
| 91 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.04576316 |
| 92 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.02974130 |
| 93 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02801372 |
| 94 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.02081462 |
| 95 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01822739 |
| 96 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01792306 |
| 97 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01491883 |
| 98 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01338496 |
| 99 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.00900131 |
| 100 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00900131 |
| 101 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00100179 |
| 102 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.98940022 |
| 103 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98796600 |
| 104 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98744529 |
| 105 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98395364 |
| 106 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.95852273 |
| 107 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.95692823 |
| 108 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.94562123 |
| 109 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94271591 |
| 110 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.94240157 |
| 111 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94169866 |
| 112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94049858 |
| 113 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.93647448 |
| 114 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.93311990 |
| 115 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93166710 |
| 116 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.93002171 |
| 117 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.92695604 |
| 118 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.91850950 |
| 119 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90251204 |
| 120 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.89048040 |
| 121 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.87356471 |
| 122 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86374098 |
| 123 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.86197010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.51857489 |
| 2 | MP0003880_abnormal_central_pattern | 4.83747655 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.15644230 |
| 4 | MP0009046_muscle_twitch | 3.68746750 |
| 5 | MP0009745_abnormal_behavioral_response | 3.59399914 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.58746146 |
| 7 | MP0004270_analgesia | 3.43492660 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.33943478 |
| 9 | MP0002064_seizures | 3.33558167 |
| 10 | MP0002736_abnormal_nociception_after | 3.02745319 |
| 11 | * MP0002572_abnormal_emotion/affect_behav | 2.87645876 |
| 12 | MP0002822_catalepsy | 2.83570847 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.50511707 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.49560642 |
| 15 | MP0001486_abnormal_startle_reflex | 2.46596714 |
| 16 | MP0002272_abnormal_nervous_system | 2.45761620 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.28683155 |
| 18 | MP0002067_abnormal_sensory_capabilities | 1.99523060 |
| 19 | MP0003879_abnormal_hair_cell | 1.96177209 |
| 20 | MP0000569_abnormal_digit_pigmentation | 1.95188746 |
| 21 | MP0001440_abnormal_grooming_behavior | 1.94449878 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.92644815 |
| 23 | MP0001970_abnormal_pain_threshold | 1.91588196 |
| 24 | MP0005423_abnormal_somatic_nervous | 1.85590561 |
| 25 | MP0004885_abnormal_endolymph | 1.80923352 |
| 26 | MP0008877_abnormal_DNA_methylation | 1.78836072 |
| 27 | MP0004811_abnormal_neuron_physiology | 1.78322484 |
| 28 | MP0008569_lethality_at_weaning | 1.77070490 |
| 29 | MP0004858_abnormal_nervous_system | 1.66973101 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.59488999 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.58974400 |
| 32 | MP0004924_abnormal_behavior | 1.58974400 |
| 33 | MP0003303_peritoneal_inflammation | 1.55491286 |
| 34 | MP0003329_amyloid_beta_deposits | 1.52299317 |
| 35 | MP0001905_abnormal_dopamine_level | 1.49049158 |
| 36 | MP0005623_abnormal_meninges_morphology | 1.46036776 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.43673187 |
| 38 | MP0003136_yellow_coat_color | 1.43301709 |
| 39 | MP0005551_abnormal_eye_electrophysiolog | 1.40890324 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.40026783 |
| 41 | MP0002184_abnormal_innervation | 1.39949785 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.39635310 |
| 43 | MP0003075_altered_response_to | 1.38112548 |
| 44 | MP0003633_abnormal_nervous_system | 1.32627956 |
| 45 | MP0001529_abnormal_vocalization | 1.28908579 |
| 46 | * MP0002066_abnormal_motor_capabilities/c | 1.27100751 |
| 47 | MP0001485_abnormal_pinna_reflex | 1.26631847 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.25965596 |
| 49 | MP0004147_increased_porphyrin_level | 1.17101234 |
| 50 | MP0000751_myopathy | 1.16277125 |
| 51 | MP0008004_abnormal_stomach_pH | 1.16180250 |
| 52 | MP0008874_decreased_physiological_sensi | 1.15564132 |
| 53 | MP0000013_abnormal_adipose_tissue | 1.14482610 |
| 54 | MP0004510_myositis | 1.14031970 |
| 55 | MP0001188_hyperpigmentation | 1.11364328 |
| 56 | MP0002638_abnormal_pupillary_reflex | 1.10622158 |
| 57 | MP0003787_abnormal_imprinting | 1.09685226 |
| 58 | MP0003631_nervous_system_phenotype | 1.09354298 |
| 59 | MP0002882_abnormal_neuron_morphology | 1.06450893 |
| 60 | MP0010386_abnormal_urinary_bladder | 1.05337387 |
| 61 | MP0000955_abnormal_spinal_cord | 1.03529826 |
| 62 | MP0000778_abnormal_nervous_system | 1.01007731 |
| 63 | MP0003122_maternal_imprinting | 0.99976400 |
| 64 | MP0001984_abnormal_olfaction | 0.98877422 |
| 65 | MP0006276_abnormal_autonomic_nervous | 0.98110261 |
| 66 | MP0004233_abnormal_muscle_weight | 0.97218991 |
| 67 | MP0000631_abnormal_neuroendocrine_gland | 0.96214295 |
| 68 | MP0004484_altered_response_of | 0.96086175 |
| 69 | MP0001177_atelectasis | 0.95747746 |
| 70 | MP0002090_abnormal_vision | 0.93145360 |
| 71 | MP0004142_abnormal_muscle_tone | 0.92442048 |
| 72 | MP0000604_amyloidosis | 0.90053037 |
| 73 | MP0008872_abnormal_physiological_respon | 0.86532663 |
| 74 | MP0000026_abnormal_inner_ear | 0.86082997 |
| 75 | MP0002837_dystrophic_cardiac_calcinosis | 0.85431758 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 0.84061652 |
| 77 | MP0005535_abnormal_body_temperature | 0.83955442 |
| 78 | MP0005410_abnormal_fertilization | 0.83161528 |
| 79 | MP0002653_abnormal_ependyma_morphology | 0.81080272 |
| 80 | MP0006292_abnormal_olfactory_placode | 0.79438362 |
| 81 | MP0004085_abnormal_heartbeat | 0.79049492 |
| 82 | MP0003121_genomic_imprinting | 0.78540295 |
| 83 | MP0002152_abnormal_brain_morphology | 0.78527570 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 0.78159442 |
| 85 | MP0005166_decreased_susceptibility_to | 0.76347457 |
| 86 | MP0002752_abnormal_somatic_nervous | 0.75265611 |
| 87 | MP0003634_abnormal_glial_cell | 0.74016330 |
| 88 | MP0008438_abnormal_cutaneous_collagen | 0.73669623 |
| 89 | MP0005503_abnormal_tendon_morphology | 0.72758559 |
| 90 | MP0004742_abnormal_vestibular_system | 0.72322133 |
| 91 | MP0003091_abnormal_cell_migration | 0.70345853 |
| 92 | MP0000920_abnormal_myelination | 0.69924177 |
| 93 | MP0003938_abnormal_ear_development | 0.68070717 |
| 94 | MP0001958_emphysema | 0.66549486 |
| 95 | MP0003632_abnormal_nervous_system | 0.65100902 |
| 96 | MP0002069_abnormal_eating/drinking_beha | 0.64921261 |
| 97 | MP0000566_synostosis | 0.64138768 |
| 98 | MP0001502_abnormal_circadian_rhythm | 0.63313092 |
| 99 | MP0001986_abnormal_taste_sensitivity | 0.62552338 |
| 100 | MP0004215_abnormal_myocardial_fiber | 0.62444460 |
| 101 | MP0005253_abnormal_eye_physiology | 0.61167279 |
| 102 | MP0005171_absent_coat_pigmentation | 0.60951087 |
| 103 | MP0003690_abnormal_glial_cell | 0.60739321 |
| 104 | MP0005409_darkened_coat_color | 0.59971400 |
| 105 | MP0004036_abnormal_muscle_relaxation | 0.59414660 |
| 106 | MP0005595_abnormal_vascular_smooth | 0.58508606 |
| 107 | MP0000579_abnormal_nail_morphology | 0.58501095 |
| 108 | MP0002229_neurodegeneration | 0.58218963 |
| 109 | MP0002876_abnormal_thyroid_physiology | 0.57893174 |
| 110 | MP0002102_abnormal_ear_morphology | 0.57865753 |
| 111 | MP0003045_fibrosis | 0.57803654 |
| 112 | MP0004043_abnormal_pH_regulation | 0.57502981 |
| 113 | MP0004883_abnormal_blood_vessel | 0.57386233 |
| 114 | MP0003137_abnormal_impulse_conducting | 0.56833361 |
| 115 | MP0006072_abnormal_retinal_apoptosis | 0.55987723 |
| 116 | MP0005394_taste/olfaction_phenotype | 0.55326423 |
| 117 | MP0005499_abnormal_olfactory_system | 0.55326423 |
| 118 | MP0001346_abnormal_lacrimal_gland | 0.55155735 |
| 119 | MP0003123_paternal_imprinting | 0.54874209 |
| 120 | MP0003279_aneurysm | 0.54047236 |
| 121 | MP0003698_abnormal_male_reproductive | 0.53633104 |
| 122 | MP0005058_abnormal_lysosome_morphology | 0.52578363 |
| 123 | MP0001664_abnormal_digestion | 0.52071304 |
| 124 | MP0010769_abnormal_survival | 0.52004567 |
| 125 | MP0002295_abnormal_pulmonary_circulatio | 0.52004281 |
| 126 | MP0004130_abnormal_muscle_cell | 0.51529976 |
| 127 | MP0004145_abnormal_muscle_electrophysio | 0.51387817 |
| 128 | MP0005164_abnormal_response_to | 0.50967920 |
| 129 | MP0001943_abnormal_respiration | 0.48212921 |
| 130 | MP0001963_abnormal_hearing_physiology | 0.48129266 |
| 131 | MP0002133_abnormal_respiratory_system | 0.45689982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.66199309 |
| 2 | Atonic seizures (HP:0010819) | 6.32659928 |
| 3 | Focal seizures (HP:0007359) | 6.04995564 |
| 4 | Myokymia (HP:0002411) | 5.78236239 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.48296774 |
| 6 | Visual hallucinations (HP:0002367) | 5.10009348 |
| 7 | Febrile seizures (HP:0002373) | 4.99707233 |
| 8 | Absence seizures (HP:0002121) | 4.86841137 |
| 9 | Dialeptic seizures (HP:0011146) | 4.47533856 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 4.03156937 |
| 11 | Poor eye contact (HP:0000817) | 3.53430687 |
| 12 | Hyperventilation (HP:0002883) | 3.45091484 |
| 13 | Abnormality of binocular vision (HP:0011514) | 3.43898864 |
| 14 | Diplopia (HP:0000651) | 3.43898864 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 3.36222678 |
| 16 | Broad-based gait (HP:0002136) | 3.20604077 |
| 17 | Impaired social interactions (HP:0000735) | 3.16911827 |
| 18 | Abnormal social behavior (HP:0012433) | 3.16911827 |
| 19 | Gaze-evoked nystagmus (HP:0000640) | 3.10702292 |
| 20 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.05477320 |
| 21 | Mutism (HP:0002300) | 2.96784965 |
| 22 | Action tremor (HP:0002345) | 2.88066929 |
| 23 | Progressive inability to walk (HP:0002505) | 2.87640402 |
| 24 | Inability to walk (HP:0002540) | 2.87348637 |
| 25 | Resting tremor (HP:0002322) | 2.75873500 |
| 26 | Truncal ataxia (HP:0002078) | 2.74011857 |
| 27 | Depression (HP:0000716) | 2.73606565 |
| 28 | Increased cerebral lipofuscin (HP:0011813) | 2.73576318 |
| 29 | Delusions (HP:0000746) | 2.70527466 |
| 30 | Abnormal eating behavior (HP:0100738) | 2.69495495 |
| 31 | Amblyopia (HP:0000646) | 2.67536333 |
| 32 | Lower limb amyotrophy (HP:0007210) | 2.57454013 |
| 33 | Supranuclear gaze palsy (HP:0000605) | 2.54489238 |
| 34 | Dysmetria (HP:0001310) | 2.52141205 |
| 35 | Dysmetric saccades (HP:0000641) | 2.50999709 |
| 36 | Epileptiform EEG discharges (HP:0011182) | 2.49919219 |
| 37 | Drooling (HP:0002307) | 2.47684394 |
| 38 | Excessive salivation (HP:0003781) | 2.47684394 |
| 39 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.47007805 |
| 40 | Impaired smooth pursuit (HP:0007772) | 2.46700423 |
| 41 | Intention tremor (HP:0002080) | 2.45036111 |
| 42 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.44491346 |
| 43 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.44491346 |
| 44 | Generalized myoclonic seizures (HP:0002123) | 2.42738937 |
| 45 | Anxiety (HP:0000739) | 2.42642717 |
| 46 | Ankle clonus (HP:0011448) | 2.42620440 |
| 47 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.42005164 |
| 48 | Stereotypic behavior (HP:0000733) | 2.41823581 |
| 49 | Hemiplegia (HP:0002301) | 2.40571183 |
| 50 | Dysdiadochokinesis (HP:0002075) | 2.37075751 |
| 51 | Limb dystonia (HP:0002451) | 2.34723306 |
| 52 | Abnormality of the corticospinal tract (HP:0002492) | 2.34527483 |
| 53 | Pheochromocytoma (HP:0002666) | 2.34085654 |
| 54 | Neurofibrillary tangles (HP:0002185) | 2.33564536 |
| 55 | Torticollis (HP:0000473) | 2.30179293 |
| 56 | Papilledema (HP:0001085) | 2.29868374 |
| 57 | Distal lower limb amyotrophy (HP:0008944) | 2.29372562 |
| 58 | Sleep apnea (HP:0010535) | 2.29039495 |
| 59 | Inappropriate behavior (HP:0000719) | 2.28405234 |
| 60 | Cerebral hypomyelination (HP:0006808) | 2.27535674 |
| 61 | Hemiparesis (HP:0001269) | 2.26715100 |
| 62 | Status epilepticus (HP:0002133) | 2.26173686 |
| 63 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.24114991 |
| 64 | Abnormality of the labia minora (HP:0012880) | 2.23371900 |
| 65 | Neuronal loss in central nervous system (HP:0002529) | 2.22074199 |
| 66 | EEG with generalized epileptiform discharges (HP:0011198) | 2.20623620 |
| 67 | Neuroendocrine neoplasm (HP:0100634) | 2.19752927 |
| 68 | Gait imbalance (HP:0002141) | 2.19125285 |
| 69 | Impaired vibratory sensation (HP:0002495) | 2.15997100 |
| 70 | Failure to thrive in infancy (HP:0001531) | 2.15548325 |
| 71 | Akinesia (HP:0002304) | 2.14998011 |
| 72 | Increased circulating renin level (HP:0000848) | 2.14582789 |
| 73 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.12223296 |
| 74 | Postural instability (HP:0002172) | 2.11246126 |
| 75 | Spinal canal stenosis (HP:0003416) | 2.09675286 |
| 76 | Protruding tongue (HP:0010808) | 2.09076312 |
| 77 | Bradykinesia (HP:0002067) | 2.07152061 |
| 78 | Megalencephaly (HP:0001355) | 2.06652187 |
| 79 | Abnormality of the periventricular white matter (HP:0002518) | 2.05988137 |
| 80 | Focal dystonia (HP:0004373) | 2.05790352 |
| 81 | Annular pancreas (HP:0001734) | 2.04883648 |
| 82 | Scanning speech (HP:0002168) | 2.04344596 |
| 83 | Hypsarrhythmia (HP:0002521) | 2.02471809 |
| 84 | Urinary urgency (HP:0000012) | 2.01038136 |
| 85 | Hypoventilation (HP:0002791) | 2.00836879 |
| 86 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.99712469 |
| 87 | Type II lissencephaly (HP:0007260) | 1.98706197 |
| 88 | Clonus (HP:0002169) | 1.96435863 |
| 89 | Abnormal ciliary motility (HP:0012262) | 1.96056975 |
| 90 | J-shaped sella turcica (HP:0002680) | 1.96048720 |
| 91 | Decreased central vision (HP:0007663) | 1.95916463 |
| 92 | Absent/shortened dynein arms (HP:0200106) | 1.95020751 |
| 93 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.95020751 |
| 94 | Insidious onset (HP:0003587) | 1.94591002 |
| 95 | Termporal pattern (HP:0011008) | 1.94591002 |
| 96 | Polyphagia (HP:0002591) | 1.91950263 |
| 97 | Incomplete penetrance (HP:0003829) | 1.91083120 |
| 98 | Medial flaring of the eyebrow (HP:0010747) | 1.90204908 |
| 99 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.89814087 |
| 100 | Heterochromia iridis (HP:0001100) | 1.88901976 |
| 101 | Absent speech (HP:0001344) | 1.88470789 |
| 102 | Cerebral inclusion bodies (HP:0100314) | 1.87388117 |
| 103 | Nephronophthisis (HP:0000090) | 1.86875565 |
| 104 | Abnormality of salivation (HP:0100755) | 1.83607772 |
| 105 | Genetic anticipation (HP:0003743) | 1.83021419 |
| 106 | Ventricular fibrillation (HP:0001663) | 1.82142760 |
| 107 | Craniofacial dystonia (HP:0012179) | 1.80063718 |
| 108 | Rapidly progressive (HP:0003678) | 1.79455606 |
| 109 | Obstructive sleep apnea (HP:0002870) | 1.77917172 |
| 110 | Retinal dysplasia (HP:0007973) | 1.77831931 |
| 111 | Abnormal drinking behavior (HP:0030082) | 1.77536045 |
| 112 | Polydipsia (HP:0001959) | 1.77536045 |
| 113 | Rigidity (HP:0002063) | 1.77508659 |
| 114 | Short chin (HP:0000331) | 1.77040322 |
| 115 | Abnormality of the lower motor neuron (HP:0002366) | 1.76868045 |
| 116 | Lower limb asymmetry (HP:0100559) | 1.76336227 |
| 117 | Protrusio acetabuli (HP:0003179) | 1.75807034 |
| 118 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.75473909 |
| 119 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.75473909 |
| 120 | Split foot (HP:0001839) | 1.73811768 |
| 121 | Impaired pain sensation (HP:0007328) | 1.73745625 |
| 122 | Abnormality of pain sensation (HP:0010832) | 1.73745625 |
| 123 | True hermaphroditism (HP:0010459) | 1.73229462 |
| 124 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.72414701 |
| 125 | Spastic gait (HP:0002064) | 1.72050062 |
| 126 | Postural tremor (HP:0002174) | 1.70519369 |
| 127 | Blue irides (HP:0000635) | 1.67998089 |
| 128 | Pancreatic fibrosis (HP:0100732) | 1.67556267 |
| 129 | Optic nerve hypoplasia (HP:0000609) | 1.67475906 |
| 130 | Dyskinesia (HP:0100660) | 1.66753330 |
| 131 | Tetraplegia (HP:0002445) | 1.66138146 |
| 132 | Buphthalmos (HP:0000557) | 1.65553972 |
| 133 | Lower limb muscle weakness (HP:0007340) | 1.64920129 |
| 134 | Gait ataxia (HP:0002066) | 1.63148023 |
| 135 | Iris hypopigmentation (HP:0007730) | 1.62867700 |
| 136 | Fetal akinesia sequence (HP:0001989) | 1.61308755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.81011264 |
| 2 | NTRK3 | 3.67034714 |
| 3 | MAP3K4 | 3.29299163 |
| 4 | MAP3K12 | 3.24090824 |
| 5 | MAP3K9 | 3.22492136 |
| 6 | DAPK2 | 3.17856173 |
| 7 | MAP2K7 | 3.11108942 |
| 8 | CASK | 2.96772594 |
| 9 | RIPK4 | 2.71297810 |
| 10 | DAPK1 | 2.57565066 |
| 11 | CDK19 | 2.34774137 |
| 12 | ARAF | 2.28271146 |
| 13 | MINK1 | 2.27935689 |
| 14 | MAP2K4 | 2.24054064 |
| 15 | PNCK | 2.15803343 |
| 16 | CAMKK1 | 2.13825817 |
| 17 | PAK6 | 2.11605485 |
| 18 | PLK2 | 2.10817183 |
| 19 | PINK1 | 2.06082130 |
| 20 | CCNB1 | 1.98818786 |
| 21 | KSR2 | 1.79295136 |
| 22 | CAMKK2 | 1.69428814 |
| 23 | NTRK1 | 1.55540045 |
| 24 | GRK5 | 1.52163489 |
| 25 | MARK1 | 1.50170549 |
| 26 | FES | 1.45287813 |
| 27 | CDK5 | 1.39982105 |
| 28 | PTK2B | 1.32892955 |
| 29 | TNIK | 1.31485543 |
| 30 | STK39 | 1.28904417 |
| 31 | NTRK2 | 1.28753042 |
| 32 | RAF1 | 1.27449123 |
| 33 | SIK2 | 1.25035506 |
| 34 | PHKG2 | 1.19543738 |
| 35 | PHKG1 | 1.19543738 |
| 36 | FRK | 1.18875960 |
| 37 | PRKD3 | 1.11575790 |
| 38 | KSR1 | 1.10796898 |
| 39 | BMPR1B | 1.09674374 |
| 40 | WNK4 | 1.08469127 |
| 41 | WNK3 | 1.06650462 |
| 42 | DAPK3 | 1.02710528 |
| 43 | PKN2 | 1.02582869 |
| 44 | MAP3K13 | 0.95770641 |
| 45 | CAMK2A | 0.95357322 |
| 46 | PRPF4B | 0.94817605 |
| 47 | PRKCG | 0.94123990 |
| 48 | PKN1 | 0.93953097 |
| 49 | DYRK1A | 0.93309687 |
| 50 | MAPKAPK5 | 0.92174337 |
| 51 | TRIB3 | 0.91976210 |
| 52 | PAK3 | 0.91734156 |
| 53 | CDK18 | 0.90698046 |
| 54 | CDK15 | 0.88513635 |
| 55 | FGR | 0.88479924 |
| 56 | CDK14 | 0.85070949 |
| 57 | MAPK13 | 0.83236203 |
| 58 | RET | 0.82184609 |
| 59 | CAMK1 | 0.80600242 |
| 60 | TAOK1 | 0.79157340 |
| 61 | CDK11A | 0.76662861 |
| 62 | CAMK2G | 0.72822823 |
| 63 | PRKCH | 0.71482687 |
| 64 | MOS | 0.71237933 |
| 65 | MAP4K2 | 0.71078717 |
| 66 | OXSR1 | 0.69641082 |
| 67 | MYLK | 0.67948545 |
| 68 | DDR2 | 0.67310666 |
| 69 | MAP2K1 | 0.65365271 |
| 70 | FGFR2 | 0.64781417 |
| 71 | LATS2 | 0.63485524 |
| 72 | PRKCE | 0.63342509 |
| 73 | CAMK2D | 0.63000163 |
| 74 | PIK3CA | 0.62869135 |
| 75 | PDPK1 | 0.62273258 |
| 76 | PDK1 | 0.61659259 |
| 77 | CAMK2B | 0.60070497 |
| 78 | TNK2 | 0.59714453 |
| 79 | BRAF | 0.58525175 |
| 80 | PIM2 | 0.58347137 |
| 81 | INSRR | 0.58094545 |
| 82 | PRKCZ | 0.57605107 |
| 83 | CSNK1G2 | 0.56673735 |
| 84 | FYN | 0.55562959 |
| 85 | ADRBK1 | 0.53985299 |
| 86 | MAPK15 | 0.53796020 |
| 87 | TYRO3 | 0.53769101 |
| 88 | SCYL2 | 0.53464280 |
| 89 | STK38 | 0.51858184 |
| 90 | SGK1 | 0.51814506 |
| 91 | BMPR2 | 0.51335474 |
| 92 | PRKG1 | 0.50873946 |
| 93 | NEK1 | 0.49951601 |
| 94 | SGK2 | 0.49500361 |
| 95 | UHMK1 | 0.49118457 |
| 96 | MAP3K2 | 0.48432937 |
| 97 | AKT3 | 0.48389492 |
| 98 | MUSK | 0.48346988 |
| 99 | DMPK | 0.48280396 |
| 100 | SGK3 | 0.46213107 |
| 101 | WNK1 | 0.45952208 |
| 102 | LMTK2 | 0.45718434 |
| 103 | STK11 | 0.45545197 |
| 104 | PRKCA | 0.45530160 |
| 105 | MAPK10 | 0.45222939 |
| 106 | SGK223 | 0.44510620 |
| 107 | SGK494 | 0.44510620 |
| 108 | FER | 0.44090727 |
| 109 | PRKACA | 0.43411155 |
| 110 | MAPK12 | 0.43152478 |
| 111 | PDK3 | 0.42386438 |
| 112 | PDK4 | 0.42386438 |
| 113 | NEK6 | 0.41737078 |
| 114 | ACVR1B | 0.41482529 |
| 115 | ERBB4 | 0.41398850 |
| 116 | CAMK1G | 0.40631088 |
| 117 | CAMK4 | 0.35164701 |
| 118 | TRIM28 | 0.34950321 |
| 119 | MARK2 | 0.34481058 |
| 120 | RIPK1 | 0.33573388 |
| 121 | DYRK2 | 0.33344197 |
| 122 | TAOK3 | 0.33309503 |
| 123 | GRK7 | 0.32485652 |
| 124 | BLK | 0.32429008 |
| 125 | RPS6KA3 | 0.32408183 |
| 126 | SIK3 | 0.31948208 |
| 127 | PRKG2 | 0.31663887 |
| 128 | CSNK1A1 | 0.31028720 |
| 129 | CLK1 | 0.30980518 |
| 130 | ADRBK2 | 0.30369739 |
| 131 | SRC | 0.30367324 |
| 132 | TTN | 0.29930344 |
| 133 | PRKCB | 0.29397044 |
| 134 | PDK2 | 0.28767368 |
| 135 | ALK | 0.28177787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.74920031 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.52952691 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.59217528 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.52901636 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.43497649 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.42624764 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.40411491 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.39406077 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.31106578 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.16742927 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.16456485 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.97464268 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 1.92092730 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.69862601 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.69804626 |
| 16 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.62419197 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 1.61716479 |
| 18 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.60745818 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.55935111 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.54702449 |
| 21 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.52463070 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.52257913 |
| 23 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.51845728 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.50562674 |
| 25 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.45754132 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.44075042 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.43295423 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.41815464 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.35046820 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.26344631 |
| 31 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.25631896 |
| 32 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23006443 |
| 33 | * Gap junction_Homo sapiens_hsa04540 | 1.21317647 |
| 34 | Glioma_Homo sapiens_hsa05214 | 1.17085440 |
| 35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14621627 |
| 36 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.10139554 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.08842679 |
| 38 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.08385096 |
| 39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.06023699 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.01530602 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.01477448 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99887687 |
| 43 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.98974396 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95249971 |
| 45 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.91174156 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.90591304 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89809661 |
| 48 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89440461 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.88947714 |
| 50 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87494829 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86851684 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85631825 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84324663 |
| 54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.84096290 |
| 55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84082886 |
| 56 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.79695403 |
| 57 | Tuberculosis_Homo sapiens_hsa05152 | 0.77956885 |
| 58 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77617563 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76239695 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75969787 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74650522 |
| 62 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.73391571 |
| 63 | Axon guidance_Homo sapiens_hsa04360 | 0.71879795 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71743576 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70112186 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69981307 |
| 67 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.69570376 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 0.68050172 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67727091 |
| 70 | Bile secretion_Homo sapiens_hsa04976 | 0.67269530 |
| 71 | Melanogenesis_Homo sapiens_hsa04916 | 0.66996451 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65952174 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65565090 |
| 74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64810379 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61794189 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.61468766 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61275008 |
| 78 | Parkinsons disease_Homo sapiens_hsa05012 | 0.60443670 |
| 79 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59869624 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59684579 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57102371 |
| 82 | Alcoholism_Homo sapiens_hsa05034 | 0.56726622 |
| 83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56267635 |
| 84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55041819 |
| 85 | Shigellosis_Homo sapiens_hsa05131 | 0.52329326 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.51154231 |
| 87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50983337 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50922288 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50652869 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.50103402 |
| 91 | Melanoma_Homo sapiens_hsa05218 | 0.49969353 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49897754 |
| 93 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49801735 |
| 94 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.48472749 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48331165 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46761174 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46484221 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46227680 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.45915800 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45897883 |
| 101 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45338902 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43974277 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43635156 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43243337 |
| 105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42750935 |
| 106 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41409285 |
| 107 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.40766833 |
| 108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.40282834 |
| 109 | Pertussis_Homo sapiens_hsa05133 | 0.40207151 |
| 110 | Phototransduction_Homo sapiens_hsa04744 | 0.39740060 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.39546563 |
| 112 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39507933 |
| 113 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39063605 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38438591 |
| 115 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38185080 |
| 116 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.37602701 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36306926 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36092317 |
| 119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31540559 |
| 120 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31254498 |
| 121 | Huntingtons disease_Homo sapiens_hsa05016 | 0.29576998 |
| 122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.29206767 |
| 123 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.28304930 |
| 124 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28149374 |
| 125 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.27472939 |
| 126 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26131571 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25785242 |
| 128 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25583353 |
| 129 | ABC transporters_Homo sapiens_hsa02010 | 0.20767599 |

